Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma

Cancer Biology and Therapy

Volumn 14, Issue 12, 2013, Pages 1104-1112

  Rani, Sweta ^a   Gately, Kathy ^b   Crown, John ^c   O'Byrne, Ken ^b   O'Driscoll, Lorraine ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Adenocarcinoma; Biomarker; Circulating; Lung cancer; Micro RNAs (miRNAs); Minimally invasive; ROC curve

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 146B 3P; MICRORNA 16; MICRORNA 192; MICRORNA 30C 1; MICRORNA 339 5P; MICRORNA 451; MICRORNA 550; MICRORNA 566; MICRORNA 616; MICRORNA 939; TUMOR MARKER; UNCLASSIFIED DRUG; UNTRANSLATED RNA; BIOLOGICAL MARKER;

AGE; AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DENSITY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENDER; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA ISOLATION; UPREGULATION; ADENOCARCINOMA; AGED; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; PROGNOSIS;

ADENOCARCINOMA; AGED; BIOMARKERS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS;

EID: 84891768715     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.26370     Document Type: Article

References (37)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300; PMID:20610543; http://dx.doi.org/10.3322/caac.20073
2. Cataldo VD, Gibbons DL, Pérez-Soler R, Quintás-Cardama A. Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N Engl J Med 2011; 364:947-55; PMID:21388312; http://dx.doi.org/10.1056/NEJMct0807960
3. Langer CJ, Besse B, Gualberto A, Brambilla E, Soria JC. The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol 2010; 28:5311-20; PMID:21079145; http://dx.doi.org/10.1200/JCO.2010.28. 8126
4. Cagle PT, Allen TC, Dacic S, Beasley MB, Borczuk AC, Chirieac LR, Laucirica R, Ro JY, Kerr KM. Revolution in lung cancer: new challenges for the surgical pathologist. Arch Pathol Lab Med 2011; 135:110-6; PMID:21204716
5. Wilkerson MD, Yin X, Walter V, Zhao N, Cabanski CR, Hayward MC, Miller CR, Socinski MA, Parsons AM, Thorne LB, et al. Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation. PLoS One 2012; 7:e36530; PMID:22590557; http://dx.doi.org/10.1371/journal.pone.0036530
6. Tarro G, Perna A, Esposito C. Early diagnosis of lung cancer by detection of tumor liberated protein. J Cell Physiol 2005; 203:1-5; PMID:15389637; http://dx.doi.org/10.1002/jcp.20195
7. O'Driscoll L, Kenny E, Mehta JP, Doolan P, Joyce H, Gammell P, Hill A, O'Daly B, O'Gorman D, Clynes M. Feasibility and relevance of global expression profiling of gene transcripts in serum from breast cancer patients using whole genome microarrays and quantitative RT-PCR. Cancer Genomics Proteomics 2008; 5:94-104; PMID:18460738
8. Friel AM, Corcoran C, Crown J, O'Driscoll L. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer. Breast Cancer Res Treat 2010; 123:613-25; PMID:20549336; http://dx.doi.org/10.1007/ s10549-010-0980-2
9. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010; 5:e13735; PMID:21060830; http://dx.doi.org/10.1371/journal.pone. 0013735
10. Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Müller SC, Ellinger J. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 2011; 77:e9-16; PMID:21539977; http://dx.doi.org/10.1016/j.urology.2011. 01.020
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105
12. Li J, Wang Y, Yu W, Chen J, Luo J. Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun 2011; 406:70-3; PMID:21295551; http://dx.doi.org/10.1016/j.bbrc.2011.01. 111
13. Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 2011; 45:355- 60; PMID:21278583; http://dx.doi.org/10.1097/MCG.0b013e3181f18ac2
14. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R, et al. A fivemicroRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 2011; 47:784-91; PMID:21112772; http://dx.doi.org/10. 1016/j.ejca.2010.10.025
15. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr., Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470-6; PMID:19011622; http://dx.doi.org/10.1038/ncb1800
16. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997-1006; PMID:18766170; http://dx.doi.org/10.1038/cr.2008.282
17. Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C, Wang C, Ren Z, Zhao Y, Wu S, et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 2012; 130:1620-8; PMID:21557218; http://dx.doi.org/10. 1002/ijc.26177
18. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC. Circulating micro- RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 2012; 130:1378-86; PMID:21544802; http://dx.doi.org/10. 1002/ijc.26153
19. Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, Ochs MF, Ahrendt SA, Mambo E, Califano JA. Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One 2012; 7:e32307; PMID:22389695; http://dx.doi.org/10.1371/journal.pone.0032307
20. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-smallcell lung cancer. J Clin Oncol 2010; 28:1721-6; PMID:20194856; http://dx.doi.org/10.1200/JCO.2009.24.9342
21. Roth C, Kasimir-Bauer S, Pantel K, Schwarzenbach H. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol Oncol 2011; 5:281-91; PMID:21398193; http://dx.doi.org/10.1016/j.molonc.2011.02.002
22. Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, Guarnera MA, Li R, Cai L, Zhan M, et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 2011; 11:374; PMID:21864403; http://dx.doi.org/10.1186/1471-2407-11-374
23. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, Guarnera M, Liao J, Chou A, Lu CL, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 2011; 91:579-87; PMID:21116241; http://dx.doi.org/10.1038/labinvest.2010.194
24. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, Croce CM, Pastorino U, Sozzi G. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011; 108:3713-8; PMID:21300873; http://dx.doi.org/10. 1073/pnas.1100048108
25. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 2011; 6:482-8; PMID:21258252; http://dx.doi.org/10.1097/ JTO.0b013e318208c785
26. Silva J, García V, Zaballos A, Provencio M, Lombardía L, Almonacid L, García JM, Domínguez G, Peña C, Diaz R, et al. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J 2011; 37:617-23; PMID:20595154; http://dx.doi.org/10.1183/09031936.00029610
27. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009; 10:42-6; PMID:19289371; http://dx.doi.org/10.3816/CLC.2009.n.006
28. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010; 16:430-41; PMID:20068076; http://dx.doi.org/10.1158/1078-0432.CCR-09-1736
29. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009; 69:5776-83; PMID:19584273; http://dx.doi.org/10.1158/0008-5472.CAN-09-0587
30. Malleter M, Jacquot C, Rousseau B, Tomasoni C, Juge M, Pineau A, Sakanian V, Roussakis C. miRNAs, a potential target in the treatment of Non- Small-Cell Lung Carcinomas. Gene 2012; 506:355-9; PMID:22732573; http://dx.doi.org/10.1016/ j.gene.2012.06.008
31. Lu Y, Govindan R, Wang L, Liu PY, Goodgame B, Wen W, Sezhiyan A, Pfeifer J, Li YF, Hua X, et al. MicroRNA profiling and prediction of recurrence/ relapse-free survival in stage I lung cancer. Carcinogenesis 2012; 33:1046-54; PMID:22331473; http://dx.doi.org/10.1093/carcin/bgs100
32. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 2010; 70:36-45; PMID:20028859; http://dx.doi.org/10.1158/0008-5472.CAN-09-3153
33. Shapiro M, Akiri G, Chin C, Wisnivesky JP, Beasley MB, Weiser TS, Swanson SJ, Aaronson SA. Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer. Ann Surg 2013; 257:548-54; PMID:23011390; http://dx.doi.org/10.1097/SLA.0b013e31826d81fd
34. Toonkel RL, Borczuk AC, Powell CA. Tgf-beta signaling pathway in lung adenocarcinoma invasion. J Thorac Oncol 2010; 5:153-7; PMID:20101143; http://dx.doi.org/10.1097/JTO.0b013e3181c8cc0c
35. Raz G, Allen KE, Kingsley C, Cherni I, Arora S, Watanabe A, Lorenzo CD, Edwards V DK, Sridhar S, Hostetter G, et al. Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage nonsmall cell lung cancer. Lung Cancer 2012; 76:191-6; PMID:22115706; http://dx.doi.org/10.1016/j. lungcan.2011.10.015
36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262 (Pubitemid 34164012)
37. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 2009; 25:1991-3; PMID:19435746; http://dx.doi.org/10.1093/bioinformatics/btp299